Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study-Reference-Cited by-同舟云学术

Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study

Published:2023 Issue:13 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Kim Bokyung¹^ORCID,Jung Jin-Hyung²^ORCID,Han Kyungdo³^ORCID,Kang Seungkyung¹^ORCID,Lee Eunwoo¹^ORCID,Chung Hyunsoo¹^ORCID,Kim Sang Gyun¹^ORCID,Cho Soo-Jeong¹^ORCID

Affiliation:

1. Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

2. Department of Biostatistics, The Catholic University College of Medicine, Seoul, Korea.

3. Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.

Funder

National Research Foundation of Korea

Korean College of Helicobacter and Upper Gastrointestinal Research

Dong-A Pharmaceutical Co.

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e99

Reference57 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

3. Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19

4. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

5. Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals